dimecres, 20 d’agost del 2014

FDA delays UDI rule for contacts, intraocular lenses




The FDA gives Class III contact and intraocular lens manufacturers a 1-year extension to comply with the Unique Device Identifier program.





FDA delays UDI rule for high-risk contacts, intraocular lenses

Makers of contact lenses and intraocular lenses are getting a 1-year reprieve after the FDA agreed to shift their due date for complying with Unique Device Identifier rules.


Manufacturers successfully lobbied for a delay after demonstrating that requirements for lenses would create a massive burden for both device makers and regulators.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qqQ24G

Cap comentari:

Publica un comentari a l'entrada